Immunological defects after suicide gene therapy of experimental graft-versus-host disease

Human Gene Therapy

Volumn 10, Issue 16, 1999, Pages 2701-2707

  Cohen, José L ^a   Lacroix Desmazes, Sébastien ^b   Charlotte, Frédéric ^c   Lejeune, Laurence ^a   Martin, Paul J ^d   Klatzmann, David ^c   Boyer, Olivier ^c  

^a Genopoietic S A R L   (France)

^b HÔPITAL BROUSSAIS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE THERAPY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; STEM CELL TRANSPLANTATION; SUICIDE GENE; T LYMPHOCYTE ACTIVATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DNA; FEMALE; GANCICLOVIR; GENE THERAPY; GRAFT VS HOST DISEASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; SPLEEN; SURVIVAL RATE; THYMIDINE KINASE;

ANIMALIA;

EID: 0033229969     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016744     Document Type: Article

References (17)

1. AVRAMEAS, S. (1991). Natural autoantibodies: From "horror autotoxicus" to "gnothi seauton." Immunol. Today 12, 154-159.
2. BORDIGNON, C., BONINI, C., VERZELETTI, S., NOBILI, N., MAGGIONI, D., TRAVERSARI, C., GIAVAZZI, R., SERVIDA, P., ZAPPONE, E., BENAZZI, E., BERNARDI, M., PORTA, F., FERRARI, G., MAVILIO, F., ROSSINI, S., BLAESE, R.M., and CANDOTTI, F. (1995). Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor antitumor immunity after allogeneic bone marrow transplantation. Hum. Gene Ther. 6, 813-819.
3. COHEN, J.L., BOYER, O., SALOMON, B., ONCLERCQ, R., CHARLOTTE, F., BRUEL, S., BOISSERIE, G., and KLATZMANN, D. (1997). Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood 89, 4636-4645.
4. COHEN, J.L., BOYER, O., SALOMON, B., ONCLERCQ, R., DEPETRIS, D., LEJEUNE, L., DUBUS-BONNET, V., BRUEL, S., CHARLOTTE, F., MATTÉÏ, M.G., and KLATZMANN, D. (1998). Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase ΔTK gene. Transgenic Res. 7, 321-330.
5. COHEN, J.L., BOYER, O., and KLATZMANN, D. (1999a). Would suicide gene therapy solve the T-cell dilemma of allogeneic bone marrow transplantation? Immunol. Today 20, 172-176.
6. COHEN, J.L., BOYER, O., THOMAS-VASLIN, V., and KLATZMANN, D. (1999b). Suicide-gene mediated modulation of graft-versus-host disease. Leukemia Lymphoma 34, 473-480.
7. DULUDE, G., ROY, D.C., and PERRAULT, C. (1999). The effect of graft-versus-host disease on T cell production and homeostasis. J. Exp. Med. 189, 1329-1341.
8. HELENE, M., LAKE-BULLOCK, V., BRYSON, J.S., JENNINGS, C.D., and KAPLAN, A.M. (1997). Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene. J. Immunol. 158, 5079-5082.
9. HIRABAYASHI, N. (1981). Studies on graft versus host (GvH) reactions. I. Impairment of hemopoietic stroma in mice suffering from GvH disease. Exp. Hematol. 9, 101-110.
10. HOROWITZ, M.M., GALE, R.P., SONDEL, P.M., GOLDMAN, J.M., KERSEY, J., KOLB, H.J., RIMM, A.A., RINGDEN, O., ROZMAN, C., TRUITT, R.L., ZWAAN, F.E., and BORTIN, M.M. (1990). Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562.
11. IWASAKI, T., FUJIWARA, H., IWASAKI, T., and SHEARER, G.M. (1986). Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction. J. Immunol. 137, 3100-3108.
12. KERNAN, N.A., BORDIGNON, C., HELLER, G., CUNNINGHAM, I., CASTRO MALASPINA, H., SHANK, B., FLOMENBERG, N., BURNS, J., YANG, S.Y., and BLACK, P. (1989). Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia. I. Analysis of risk factors and results of secondary transplants. Blood 74, 2227-2236.
13. LINK, C.J., JR., BURT, R.K., TRAYNOR, A.E., DROBYSKI, W.R., SEREGINA, T., LEVY, J.P., GORDON, L., ROSEN, S.T., BURNS, W.H., CAMITTA, B., CASPER, J., HOROWITZ, M., JUCKETT, M., et al. (1998). Adoptive immunotherapy for leukemia: Donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. Hum. Gene Ther. 9, 115-134.
14. MACKALL, C., GRANGER, L., SHEARD, M., CEPEDA, R., and GRESS, R. (1993). T-cell regeneration after bone marrow transplantation: Differential CD45 isoform expression on thymid-derived versus thymic-independent progeny. Blood 82, 2585-2594.
15. SMALL, T.N., PAPADOPOULOS, E.B., BOULAD, F., BLACK, P., CASTRO-MALASPINA, H., CHILDS, B.H., COLLINS, N., GILLIO, A., GEORGE, D., JAKUBOWSKI, A., HELLER, G., FAZZARI, M., KERNAN, N., MACKINNON, S., SZABOLCS, P., YOUNG, J.W., and O'REILLY, R.J. (1999). Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood 93, 467-480.
16. THOMAS, E., STORB, R., CLIFT, R.A., FEFER, A., JOHNSON, F.L., NEIMAN, P.E., LERNER, K.G., GLUCKSBERG, H., and BUCKNER, C.D. (1975). Bone-marrow transplantation. N. Engl. J. Med. 292, 832-843.
17. TIBERGHIEN, P., CAHN, J.Y., BRION, A., DECONINCK, E., RACADOT, E., HERVE, P., MILPIED, N., LIOURE, B., GLUCKMAN, E., BORDIGONI, P., JACOB, W., CHIANG, Y., MARCUS, S., REYNOLDS, C., and LONGO, D. (1997). Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study. Hum. Gene Ther. 8, 615-624.